Iranian COVID-19 vaccine

Total:19

  • Reza A’alizadeh, the innovator of the vaccine COVIRAN Barekat 2022-11-05 18:00

    By Faranak Bakhtiari

    COVIRAN, a source of honor for nation

    TEHRAN – Iran was the first country to acquire the knowledge of producing a vaccine against the coronavirus, Reza A’alizadeh, the innovator of the vaccine COVIRAN Barkat, told the Tehran Times in an exclusive interview.

  • Over 161m doses of COVID vaccine imported 2022-04-18 19:00

    Over 161m doses of COVID vaccine imported

    TEHRAN – Iran has so far imported more than 161,933,728 doses of vaccine to combat the coronavirus pandemic.

  • Iranian mRNA vaccine to start clinical trial 2022-03-12 17:36

    Iranian mRNA vaccine to start clinical trial

    TEHRAN – The Iranian mRNA vaccine for coronavirus has received permission from the Food and Drug Administration to enter phase one of the human trials, said a member of the scientific committee of the National Headquarters for Coronavirus Control.

  • West Asia’s largest COVID-19 vaccine plant inaugurated in Iran 2022-03-08 20:51

    West Asia’s largest COVID-19 vaccine plant inaugurated in Iran

    TEHRAN – Iran on Tuesday officially inaugurated a coronavirus vaccine production unit which is said to be the largest of its kind in West Asia.

  • “Noora” vaccine receives emergency use license 2022-03-01 18:07

    “Noora” vaccine receives emergency use license

    TEHRAN – Noora coronavirus vaccine, developed and produced by Baqiyatallah University of Medical Sciences, affiliated with the Islamic Revolution Guards Corps (IRGC), has received an emergency use license.

  • 76% of students aged 12-18 inoculated 2022-02-20 18:39

    76% of students aged 12-18 inoculated

    TEHRAN – Some 76 percent of the students aged 12-18 years have received the second dose of the COVID-19 vaccine, according to the latest announcement of the Ministry of Education.

  • “Noora” vaccine produces strong neutralizing antibodies: study 2022-02-18 17:36

    “Noora” vaccine produces strong neutralizing antibodies: study

    TEHRAN – The results of the first and second phases of the clinical trial showed that “Noora” vaccine produces very strong neutralizing antibodies against coronavirus.

  • Spikogen vaccine approved for third dose injection 2022-01-14 17:08

    Spikogen vaccine approved for third dose injection

    TEHRAN – The Food and Drug Administration on Thursday authorized Spikogen coronavirus vaccines as a booster dose of all vaccines, deputy health minister Kamal Heydari has said.

  • Intl. journals publish seven articles on Iran-Cuba vaccine 2022-01-04 16:18

    Intl. journals publish seven articles on Iran-Cuba vaccine

    TEHRAN – Seven articles on different stages of development and clinical trials of the Iranian-Cuban coronavirus vaccine have been published in prestigious international journals.

  • IRGC’s “Noora” vaccine begins third phase of human trial 2022-01-02 17:11

    IRGC’s “Noora” vaccine begins third phase of human trial

    TEHRAN – Noora coronavirus vaccine, developed and produced by Baqiyatallah University of Medical Sciences, affiliated with the Islamic Revolution Guards Corps (IRGC), entered the third phase of the human trial on Sunday.

  • Negotiations underway to export Razi Cov Pars vaccine 2021-12-31 17:04

    Negotiations underway to export Razi Cov Pars vaccine

    TEHRAN – A number of countries have requested to purchase the Iranian-made Cov Pars vaccine for COVID-19, and negotiations are underway to take the necessary measures for export, vice president for research and technology of Razi Vaccine and Serum Research Institute, said.

  • Iran outpaces Europe in first-dose COVID-19 vaccination 2021-11-23 17:59

    Iran outpaces Europe in first-dose COVID-19 vaccination

    TEHRAN – The national average for the first dose vaccination of people over the age of 12 was 82 percent in Iran, while it was 64 percent in Europe, Mohammad Mehdi Gooya, head of the diseases management center of the Ministry of Health, said.

  • COVIRAN vaccine to begin clinical trial on children aged 12-18 2021-11-12 17:12

    COVIRAN vaccine to begin clinical trial on children aged 12-18

    TEHRAN – COVIRAN BAREKAT vaccine received a license to start a clinical trial on children aged 12 to 18 by the next week, Minoo Mohraz, a member of the National Scientific Committee of COVID-19, has said.

  • Monthly COVID-19 vaccine output reaches 10m doses 2021-11-07 17:39

    Monthly COVID-19 vaccine output reaches 10m doses

    TEHRAN – The domestic manufacturers of coronavirus vaccine have managed to increase their monthly production to 10 million doses, Seyed Heydar Mohammadi, an official with the Food and Drug Administration, has said.

  • Some 24% of students vaccinated nationwide 2021-11-06 16:38

    Some 24% of students vaccinated nationwide

    TEHRAN – A total of 1,572,380 students, equaling 24 percent of the target group aged 12 to 18 nationwide, have received both doses of coronavirus vaccine, Azam Goudarzi, a health ministry official, said on Saturday.

  • S. Korea to provide Iran with 1m doses of COVID vaccine 2021-10-25 19:00

    S. Korea to provide Iran with 1m doses of COVID vaccine

    TEHRAN - South Korea will soon offer 1 million doses of AstraZeneca vaccine to Iran, on humanitarian grounds, to help address its vaccine shortage, Seoul's foreign ministry said Monday.

  • Nasal dose of COV Pars reduces virus transmission by 90% 2021-10-12 17:53

    Nasal dose of COV Pars reduces virus transmission by 90%

    TEHRAN – The inhaled dose of COV Pars vaccine reduces the transmission of delta and alpha coronavirus variants by up to 90 percent, Ali Es’haqi, head of Razi Vaccine and Serum Institute, has said.

  • Spikogen vaccine licensed for emergency use 2021-10-08 17:22

    Spikogen vaccine licensed for emergency use

    TEHRAN – The Food and Drug Administration has issued an emergency permit for the Iranian-Australian Spikogen vaccine, IRNA reported on Thursday.

  • Fakhra vaccine enters third phase of human test 2021-09-13 17:16

    Fakhra vaccine enters third phase of human test

    TEHRAN – The third phase of the Fakhra vaccine’s human trial started on Monday by being administrated to 40,000 volunteers, IRIB reported.